CLINICAL_TRIALS
trial_result
· 2013-11-15
Clinical Trial Update: A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia [Phase 2]
Summary
Allergan's Phase 2 trial of AGN-214868 for postherpetic neuralgia has completed, and results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Neuralgia, Postherpetic | Phase 2 | Status: COMPLETED | Results posted: 2013-11-15